Basic Information
ID: ALA710914
Type: Functional
Description: Anti MDR activity was expressed as MDR ratio or MDR fold reversal in doxorubicin resistant human breast carcinoma tumor cell line MCF-7/DOX
Organism: Homo sapiens
Cell type: MCF7-DOX
Activity Charts
Bioactivity
Activity Types for Assay ALA710914
MDR ratio
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 280.42 | 3.88 | 3.88 |
| 314.86 | 4.53 | 4.53 |
| 407.51 | 4.95 | 4.95 |
| 399.97 | 5.97 | 5.97 |
| 318.87 | 4.89 | 4.89 |
| 284.43 | 4.24 | 4.24 |
| 403.98 | 3.94 | 3.94 |
| 352.43 | 5.26 | 5.26 |
| 284.43 | 4.24 | 4.24 |
| 437.53 | 4.31 | 4.31 |
| 304.85 | 4.50 | 4.50 |
| 373.95 | 4.58 | 4.58 |
| 318.87 | 4.89 | 4.89 |
| 334.87 | 3.91 | 3.91 |
| 290.82 | 4.29 | 4.29 |
| 304.85 | 4.55 | 4.55 |
| 434.53 | 4.60 | 4.60 |
| 343.92 | 5.97 | 5.97 |
| 301.84 | 4.80 | 4.80 |
| 355.93 | 6.11 | 6.11 |
| 315.87 | 5.19 | 5.19 |
| 400.98 | 4.24 | 4.24 |
| 349.42 | 5.55 | 5.55 |
| 334.87 | 4.60 | 4.60 |
| 318.87 | 4.89 | 4.89 |
| 318.87 | 4.89 | 4.89 |
| 434.53 | 4.60 | 4.60 |
| 330.52 | 4.96 | 4.96 |
| 350.87 | 4.31 | 4.31 |
| 346.93 | 5.67 | 5.67 |
| 386.95 | 3.85 | 3.85 |
| 332.90 | 5.28 | 5.28 |
| 350.87 | 4.31 | 4.31 |
| 402.99 | 4.33 | 4.33 |
| 315.87 | 5.19 | 5.19 |
| 343.92 | 5.97 | 5.97 |
| 301.84 | 4.80 | 4.80 |
| 355.93 | 6.11 | 6.11 |
| 349.42 | 5.55 | 5.55 |